Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Neuro-Oncology
|
June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas
Hiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Journal of Neuro-Oncology
|
December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results
Marta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802
Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404
Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Neuro-Oncology Advances
|
August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
Ian F Parney, S Keith Anderson, Michael P Gustafson, et al.
Neurosurgery
|
September 8, 2005
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival
Paul D Brown, Matthew J Maurer, Teresa A Rummans, et al.
Cancer Research
|
October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
Robert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02
Roshan S Prabhu, Minhee Won, Edward G Shaw, et al.
Journal of Pain and Symptom Management
|
August 21, 2007
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients
Dona E C Locke, Paul A Decker, Jeff A Sloan, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Neuro-Oncology
|
June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas
Hiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Journal of Neuro-Oncology
|
December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results
Marta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802
Edward G Shaw, Meihua Wang, Stephen W Coons, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404
Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Neuro-Oncology Advances
|
August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
Ian F Parney, S Keith Anderson, Michael P Gustafson, et al.
Neurosurgery
|
September 8, 2005
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival
Paul D Brown, Matthew J Maurer, Teresa A Rummans, et al.
Cancer Research
|
October 19, 2006
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
Robert B Jenkins, Hilary Blair, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02
Roshan S Prabhu, Minhee Won, Edward G Shaw, et al.
Journal of Pain and Symptom Management
|
August 21, 2007
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients
Dona E C Locke, Paul A Decker, Jeff A Sloan, et al.
Page
of 14